Drug Development

Clinical Trials Cancer Drugs Regulatory Affairs Oncology Weight Loss Drugs Cancer Treatment Market Competition Alzheimer's Disease Innovative Therapies Monoclonal Antibodies

3 ARTICLES

last wk.

Nonhormonal Male Pill YCT-529 Clears First Human Safety Trial

Backed by favorable safety data with a two-to-three-day half-life, YCT-529 is now entering efficacy studies to evaluate its impact on sperm production.

21 ARTICLES

last wk.

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030

16 ARTICLES

2w ago

Sarepta Shares Plummet on FDA Review of Elevidys Following Third Patient Death

4 ARTICLES

2w ago

One-Third of Common Non-Antibiotics Undermine Gut Defenses, Fueling Salmonella Growth

3 ARTICLES

2w ago

UBC Okanagan Validates Vascularized 3D-Printed Lung Tissue Model

4 ARTICLES

2w ago

WHO Endorses Twice-Yearly HIV Prevention Jab as Early Adopters Plan 2026 Rollout

4 ARTICLES

2w ago

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

5 ARTICLES

2w ago

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

10 ARTICLES

3w ago

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

3 ARTICLES

4w ago

AP1M1 Knockout Validated to Enhance Antisense Drug Delivery, Guiding Broader RNA Therapy Development

5 ARTICLES

4w ago

Amine-Functionalized Graphene Oxide Reactor Enables Ultrafast Beta-Blocker Production

3 ARTICLES

last mo.

Charities Unite to Fast-Track Alzheimer’s and Parkinson’s Treatments Through Drug Repurposing

29 ARTICLES

last mo.

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

4 ARTICLES

last mo.

Lotte Biologics Wins Manufacturing Deal to Produce Ottimo Pharma’s Jankistomig

3 ARTICLES

last mo.

AI-Powered Discovery Yields WYS-694, a Broad-Spectrum Coronavirus Antiviral

5 ARTICLES

last mo.

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

Particle.news

Drug Development

Nonhormonal Male Pill YCT-529 Clears First Human Safety Trial

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030

Sarepta Shares Plummet on FDA Review of Elevidys Following Third Patient Death

One-Third of Common Non-Antibiotics Undermine Gut Defenses, Fueling Salmonella Growth

UBC Okanagan Validates Vascularized 3D-Printed Lung Tissue Model

WHO Endorses Twice-Yearly HIV Prevention Jab as Early Adopters Plan 2026 Rollout

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

AP1M1 Knockout Validated to Enhance Antisense Drug Delivery, Guiding Broader RNA Therapy Development

Never miss stories about

Drug Development

Researchers Extract Potent Anti-Leukemia Agents from Toxic Aspergillus flavus

Fungus-Derived Asperigimycins Show Potent Activity Against Leukemia Cells

Researchers Transform Ancient Tomb Fungus Into Potent Antileukemia Compound

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

Amine-Functionalized Graphene Oxide Reactor Enables Ultrafast Beta-Blocker Production

Charities Unite to Fast-Track Alzheimer’s and Parkinson’s Treatments Through Drug Repurposing

FDA Approves Twice-Yearly Lenacapavir Injection for HIV Prevention

Lotte Biologics Wins Manufacturing Deal to Produce Ottimo Pharma’s Jankistomig

AI-Powered Discovery Yields WYS-694, a Broad-Spectrum Coronavirus Antiviral

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

Never miss stories about

Drug Development